Open Access
J Extra Corpor Technol
Volume 55, Number 3, September 2023
Page(s) 134 - 137
Published online 08 September 2023
  1. Perico L, Benigni A, Casiraghi F, Ng L, Renia L, Remuzzi G (2021) Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 17(1), 46–64. [CrossRef] [PubMed] [Google Scholar]
  2. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324(8), 782–793. [CrossRef] [PubMed] [Google Scholar]
  3. Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord 21(4), 495–507. [CrossRef] [PubMed] [Google Scholar]
  4. Tonna JE, Abrams D, Brodie D, Greenwood JC, Rubio Mateo-Sidron JA, Usman A, Fan E (2021) Management of adult patients supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J 67(6), 601–610. [CrossRef] [PubMed] [Google Scholar]
  5. Berlin DA, Gulick RM, Martínez FJ (2020) Severe COVID-19. N Engl J Med 383(25), 2451–2460. [CrossRef] [PubMed] [Google Scholar]
  6. Pal R, Banerjee M (2020) COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 43(7), 1027–1031. [CrossRef] [PubMed] [Google Scholar]
  7. Husain-Syed F, Ronco C, Wiech T, Hecker M, Seeger W (2021) COVID-19: Spot urine rather than bronchoalveolar lavage fluid analysis? Crit Care (London, England) 25(1), 162. [CrossRef] [PubMed] [Google Scholar]
  8. Misgar RA, Rasool A, Wani AI, Bashir MI (2021) Central Diabetes Insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J Endocrinol Invest 44, 2855–2856. [CrossRef] [PubMed] [Google Scholar]
  9. Rajevac H, Bachan M, Khan Z (2020) Diabetes insipidus as a symptom of COVID-19 infection: case report. Chest 158(4), A2576. [CrossRef] [Google Scholar]
  10. Sheikh AB, Javaid MA, Sheikh A, Shekhar R (2021) Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J 38, 222. [PubMed] [Google Scholar]
  11. Sheikh AB, Javed N, Sheikh A, Upadhyay S, Shekhar R (2021) Diabetes Insipidus and concomitant myocarditis: a late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep 9, 2324709621999954. [PubMed] [Google Scholar]
  12. Christ-Crain M, Winzeler B, Refardt J (2021) Diagnosis and management of diabetes insipidus for the internist: an update. J Intern Med 290(1), 73–87. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.